BRS5-3-8 - Neurotransmitter Precursor Biotransformation & Availability
1. Mission & Overview
Mission
Maintain gut-side processing that shapes neurotransmitter precursor availability.
Intervention Dominance: Diet-Supported — Dietary Requirements
- Tryptophan
- Apple pectin (studied preparation)
- Pyridoxal 5′-phosphate (PLP; active vitamin B6 cofactor)
- Fermentable fibre resource pool
Overview
Gut microbes share substrates and compete for amino acids. Their processing can divert tryptophan into different metabolites before the host uses it. A tested pectin exposure redirected that processing in microbial communities and mice. These results explain gut-side precursor handling; they do not establish more brain serotonin, dopamine or better cognition. [2]
- Benefits: Maintaining appropriate gut-side precursor handling may influence the molecules available to the host. Benefits for brain neurotransmission remain unestablished by the processing experiments.
- Implementation Notes: Tryptophan supplies the studied microbial reactions. Apple pectin changed competing routes in the tested systems; neither result justifies a general protein, vitamin or plant-diversity checklist.
- Biological Relevance: Microbial metabolites, host precursor pools, blood–brain transport and neuronal synthesis are separate steps. Predicted genes are not measured enzyme activity or precursor delivery.
2. Primary Biological Effects
- A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism. [2]
- E. coli tryptophanase contains bound pyridoxal 5′-phosphate in its holo structure. [6]
3. Intervention Levers
No separately adjudicated practice is admitted in this assessment. This is not evidence that no practice can affect the mechanism.
No separately adjudicated lifestyle lever is admitted in this assessment.
4. Mechanistic Basis
Summary
A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism. [2]
Biological process
The immediate substrate is tryptophan, and the defined carbohydrate exposure affects microbial processing; neither establishes central neurotransmitter benefit. [2]
Mechanism Boundary
Microbial metabolites, host precursor pools, blood–brain transport and neuronal synthesis are separate steps. Predicted genes are not measured enzyme activity or precursor delivery.
Integration
This PM contributes its specific process to its parent FM. Shared inputs do not merge distinct jobs or prove an integrated clinical outcome.
4.1 Scientific Findings (3)
Summary
Pectin experiments connect microbial cross-feeding, tryptophanase repression and altered tryptophan metabolites. Structural evidence confirms the enzyme’s PLP cofactor. Human taxonomic/reward associations do not establish precursor flux or clinical benefit. [2] [1] [6]
A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism.
What this means
The immediate substrate is tryptophan, and the defined carbohydrate exposure affects microbial processing; neither establishes central neurotransmitter benefit.
Evidence confidence: Not yet scored
Finding ID: PM8-F1
Finding Statement: A tested apple-pectin exposure altered microbial cross-feeding and tryptophan metabolism.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The immediate substrate is tryptophan, and the defined carbohydrate exposure affects microbial processing; neither establishes central neurotransmitter benefit.
Synthesis Limitations: Culture, human-derived faecal communities and mouse results are not human brain precursor-flux measurements.
Evidence Considered:
- Study
- Defined cultures, human-derived faecal communities and humanised mice with apple pectin.
- Population
- Defined cultures, human-derived faecal communities and humanised mice with apple pectin.
- Result
- Carbohydrate cross-feeding repressed E. coli tryptophanase and shifted tryptophan metabolites, including routes involving C. sporogenes.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Carbohydrate cross-feeding repressed E. coli tryptophanase and shifted tryptophan metabolites, including routes involving C. sporogenes.
- Limitations
- Preserve tested preparation and systems; metabolite changes do not show brain tryptophan entry or serotonin synthesis.
- Evidence Source
- Bounded external search
- Reference
- [2]
- Study
- Attached review of host/microbial tryptophan pathways.
- Population
- Attached review of host/microbial tryptophan pathways.
- Result
- Multiple competing routes and compartments connect gut tryptophan handling with host physiology.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Multiple competing routes and compartments connect gut tryptophan handling with host physiology.
- Limitations
- Review context is not a food intervention or measured neuronal outcome.
- Evidence Source
- Bounded external search
- Reference
- [1]
Connected / Supportive Evidence:
- Jiang et al. (2018) [3]Why relevant: Attached corpus assessed for connection to this PM; preserved in the draft evidence inventory.Why excluded from the primary synthesis: Taxonomic/symptom association; does not measure the PM’s microbial effector, barrier, nerve or precursor flux.
- Steckler et al. (2024) [4]Why relevant: Attached corpus assessed for connection to this PM; preserved in the draft evidence inventory.Why excluded from the primary synthesis: Cross-sectional faecal SCFAs and microbiota; concentration is not synthesis flux, causal mediation or a treatment outcome.
- Aarts et al. (2017) [5]Why relevant: Attached corpus assessed for connection to this PM; preserved in the draft evidence inventory.Why excluded from the primary synthesis: Predicted phenylalanine-pathway potential and reward-imaging association; not measured precursor flux, absorption or neural delivery.
E. coli tryptophanase contains bound pyridoxal 5′-phosphate in its holo structure.
What this means
The enzyme’s cofactor role is established; dietary vitamin B6 limitation of this microbial route is not established.
Evidence confidence: Not yet scored
Finding ID: PM8-F2
Finding Statement: E. coli tryptophanase contains bound pyridoxal 5′-phosphate in its holo structure.
Synthesised Evidence Confidence: Not yet scored
Synthesis: The enzyme’s cofactor role is established; dietary vitamin B6 limitation of this microbial route is not established.
Synthesis Limitations: Microbial cofactor synthesis, availability and host delivery must be assessed separately.
Evidence Considered:
- Study
- Crystallographic comparison of E. coli holo and semi-holo tryptophanase.
- Population
- Crystallographic comparison of E. coli holo and semi-holo tryptophanase.
- Result
- Holo enzyme contained PLP bound to the active-site lysine, with conformation differences from apo enzyme.
- Effect / Magnitude
- Only extracted comparisons retained; no pooled effect or clinical-benefit magnitude assigned.
- Evidence Summary
- Holo enzyme contained PLP bound to the active-site lysine, with conformation differences from apo enzyme.
- Limitations
- Structural dependency does not establish that host vitamin B6 intake limits microbial activity.
- Evidence Source
- Bounded external search
- Reference
- [6]
Specific fibres altered microbial tryptophan metabolites in donor cultures; responses and metabolite pathways differed.
What this means
Inulin did not show the same significant biomass-normalised IPA result as several other fibres. Exact beta-glucan linkage/source requires supplementary-material resolution before a food-class admission. No host exposure or brain serotonin effect.
Evidence confidence: Not yet scored
Finding ID: PM8-F3
Finding Statement: Specific fibres altered microbial tryptophan metabolites in donor cultures; responses and metabolite pathways differed.
Synthesised Evidence Confidence: Not yet scored
Synthesis: Specific fibres altered microbial tryptophan metabolites in donor cultures; responses and metabolite pathways differed.
Synthesis Limitations: Inulin did not show the same significant biomass-normalised IPA result as several other fibres. Exact beta-glucan linkage/source requires supplementary-material resolution before a food-class admission. No host exposure or brain serotonin effect.
Evidence Considered:
- Study
- 5 mM tryptophan plus individually tested fibres at 3 g/L; 48-hour culture.
- Population
- Sixteen healthy-donor faecal cultures and defined-strain experiments.
- Result
- Specific fibres altered microbial tryptophan metabolites in donor cultures; responses and metabolite pathways differed.
- Effect / Magnitude
- Only the specified source-level endpoint is assessed; no pooled effect or food-dose estimate is inferred.
- Evidence Summary
- UHPLC-measured indole products, biomass-normalised comparisons and pure-strain cross-feeding.
- Limitations
- Inulin did not show the same significant biomass-normalised IPA result as several other fibres. Exact beta-glucan linkage/source requires supplementary-material resolution before a food-class admission. No host exposure or brain serotonin effect.
- Evidence Source
- Bounded external search
- Reference
- [7]
Evidence Dependency:
- The source-specific observations support different links; food composition, biochemical identity, intervention exposure and clinical outcomes are not interchangeable. Reuse across PMs is not independent replication.
5. BRS Pathways and Connections
5.1 BRS Pathways
No newly adjudicated pathway is established by this assessment.
5.2 Cross-BRS Mechanism Relationships
Existing connected mechanisms remain candidates in the review history; no new downstream admission is inferred.
5.3 Local BRS Mechanism Relationships
- BRS5-FM2-PM4 — Microbial Substrate-Processing Selection & Adaptation: related process for scope comparison; this link does not admit a newly characterised dependency.
- BRS5-FM3-PM7 — Vagal / ENS Signalling Modulation: related process for scope comparison; this link does not admit a newly characterised dependency.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
No direct functional outcome relationship currently mapped.
Stage 2A/2B dietary-target assessment — 23 October 2026
REVIEW REQUIRED. Microbial tryptophan routing and precursor/metabolite availability.
Add a primary donor-culture Finding, retaining positive fibre-specific metabolite results and the inulin contrast. Hold beta-glucan admission pending tested linkage/source resolution and dietary material matching. Do not relabel soluble potato starch as resistant starch or claim foods supply IPA directly.
New implementation: 0 dietary-input admissions (0 completed Unset candidates), 0 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.
Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.
8. References
- [1] O'Mahony et al. (2015) — Serotonin, Tryptophan Metabolism and the Brain-gut-microbiome Axis
- [2] Sinha et al. (2024) — Dietary Fibre Directs Microbial Tryptophan Metabolism via Metabolic Interactions in the Gut
- [3] Jiang et al. (2018) — Gut Microbiota Profiles in Treatment-naïve Children with Attention Deficit Hyperactivity Disorder
- [4] Steckler et al. (2024) — Dysbiosis and Decreased Short-chain Fatty Acids
- [5] Aarts et al. (2017) — Gut Microbiome in ADHD and Its Relation to Neural Reward Anticipation
- [6] Kogan et al. (2015) — Structures of Escherichia coli tryptophanase in holo and semi-holo forms
- [7] Zünd et al. (2025) — Novel cross-feeding human gut microbes metabolizing tryptophan to indole-3-propionate.
No validated structured conversion route is currently projected for this PM. This does not remove or reclassify its existing dietary inputs.
Mapping state: admitted-food-coverage-gap.